Longitude Capital
Last updated:
Investment Thesis
Longitude Capital invests in transformative healthcare companies—biotechnology, medical technology, and health solutions—that improve clinical outcomes, enhance patient quality of life, and reduce cost of care through venture growth investments in clinically de-risked, commercially-staged assets.
Investment Profile
- Stage: Clinical Stage, Commercial Stage, Growth, Late Stage
- Sectors: Biotechnology, Medical Technology, Health Solutions, Diagnostics, Surgical Devices, Therapeutics
- Geography: US
Frequently Asked Questions
What does Longitude Capital invest in?
Longitude Capital is a clinical stage, commercial stage, growth, late stage stage Biotechnology, Medical Technology, Health Solutions, Diagnostics, Surgical Devices, Therapeutics investor, primarily investing in US. Their thesis: Longitude Capital invests in transformative healthcare companies—biotechnology, medical technology, and health solutions—that improve clinical outcomes, enhance patient quality of life, and reduce cost of care through venture growth investments in clinically de-risked, commercially-staged assets.
How do I get a meeting with Longitude Capital?
Use DryPowder's AI fund matching to see exactly how your startup aligns with Longitude Capital's thesis and portfolio. The tool gives you a fit score and specific talking points tailored to Longitude Capital's focus areas (Biotechnology, Medical Technology, Health Solutions, Diagnostics, Surgical Devices, Therapeutics), so you can approach them with confidence.
Is Longitude Capital actively deploying capital?
DryPowder tracks deployment signals for Longitude Capital — including recent deals, LP closes, and portfolio news. Signal subscribers get real-time alerts when Longitude Capital makes moves, so you can reach out when the timing is right.
Is Longitude Capital right for your startup?
Use DryPowder's AI fund matching to see how Longitude Capital compares to your raise profile — and find the best-fit investors from 500+ tracked funds.